Editorial: Acute myeloid leukemia (AML): Is it time for MRD-driven treatment?

Detalles Bibliográficos
Autores principales: Guolo, Fabio, Cerchione, Claudio, Vernarecci, Chiara, Isidori, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502001/
https://www.ncbi.nlm.nih.gov/pubmed/36158678
http://dx.doi.org/10.3389/fonc.2022.1020185
_version_ 1784795605618393088
author Guolo, Fabio
Cerchione, Claudio
Vernarecci, Chiara
Isidori, Alessandro
author_facet Guolo, Fabio
Cerchione, Claudio
Vernarecci, Chiara
Isidori, Alessandro
author_sort Guolo, Fabio
collection PubMed
description
format Online
Article
Text
id pubmed-9502001
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95020012022-09-24 Editorial: Acute myeloid leukemia (AML): Is it time for MRD-driven treatment? Guolo, Fabio Cerchione, Claudio Vernarecci, Chiara Isidori, Alessandro Front Oncol Oncology Frontiers Media S.A. 2022-09-09 /pmc/articles/PMC9502001/ /pubmed/36158678 http://dx.doi.org/10.3389/fonc.2022.1020185 Text en Copyright © 2022 Guolo, Cerchione, Vernarecci and Isidori https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Guolo, Fabio
Cerchione, Claudio
Vernarecci, Chiara
Isidori, Alessandro
Editorial: Acute myeloid leukemia (AML): Is it time for MRD-driven treatment?
title Editorial: Acute myeloid leukemia (AML): Is it time for MRD-driven treatment?
title_full Editorial: Acute myeloid leukemia (AML): Is it time for MRD-driven treatment?
title_fullStr Editorial: Acute myeloid leukemia (AML): Is it time for MRD-driven treatment?
title_full_unstemmed Editorial: Acute myeloid leukemia (AML): Is it time for MRD-driven treatment?
title_short Editorial: Acute myeloid leukemia (AML): Is it time for MRD-driven treatment?
title_sort editorial: acute myeloid leukemia (aml): is it time for mrd-driven treatment?
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502001/
https://www.ncbi.nlm.nih.gov/pubmed/36158678
http://dx.doi.org/10.3389/fonc.2022.1020185
work_keys_str_mv AT guolofabio editorialacutemyeloidleukemiaamlisittimeformrddriventreatment
AT cerchioneclaudio editorialacutemyeloidleukemiaamlisittimeformrddriventreatment
AT vernareccichiara editorialacutemyeloidleukemiaamlisittimeformrddriventreatment
AT isidorialessandro editorialacutemyeloidleukemiaamlisittimeformrddriventreatment

Ejemplares similares